CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 102 filers reported holding CYTEK BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,042 | -12.9% | 188,813 | +34.9% | 0.01% | +33.3% |
| Q2 2023 | $1,196 | +55.1% | 139,997 | +66.8% | 0.01% | 0.0% |
| Q1 2023 | $771 | -41.4% | 83,911 | -34.8% | 0.01% | -43.8% |
| Q4 2022 | $1,315 | -99.6% | 128,754 | +526.7% | 0.02% | +300.0% |
| Q3 2022 | $302,000 | -8.5% | 20,545 | -33.3% | 0.00% | 0.0% |
| Q2 2022 | $330,000 | +123.0% | 30,790 | +346.9% | 0.00% | +300.0% |
| Q3 2021 | $148,000 | – | 6,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $22,533,000 | 12.24% |
| Miura Global Management | 1,649,400 | $17,698,000 | 12.14% |
| RA Capital Management | 13,381,054 | $143,578,000 | 3.83% |
| HHLR ADVISORS, LTD. | 8,757,030 | $93,963,000 | 2.01% |
| PURA VIDA INVESTMENTS, LLC | 477,164 | $5,120,000 | 0.30% |
| RTW INVESTMENTS, LP | 916,838 | $9,838,000 | 0.25% |
| Glenview Capital Management | 500,000 | $5,365,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 73,743 | $791,000 | 0.12% |
| Parkwood LLC | 42,292 | $454,000 | 0.08% |
| Point72 Asset Management, L.P. | 1,536,079 | $16,482,000 | 0.07% |